메뉴 건너뛰기




Volumn 7, Issue 3, 2008, Pages 133-140

Estimate of infant HIV-free survival at 6 to 8 weeks of age due to maternal antiretroviral prophylaxis in sub-Saharan Africa, 2004-2005

Author keywords

antiretroviral prophylaxis; HIV 1; HIV free survival; prevention of mother to child transmission; sub Saharan Africa

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

EID: 59049090412     PISSN: 15451097     EISSN: 15570886     Source Type: Journal    
DOI: 10.1177/1545109708318517     Document Type: Article
Times cited : (4)

References (30)
  • 1
    • 1642330378 scopus 로고    scopus 로고
    • UNAIDS and World Health Organization
    • UNAIDS and World Health Organization. AIDS epidemic update: 2007. http://data.unaids.org/pub/EPISlides/2007/2007-epiupdate-en.pdf. Accessed January 10, 2008.
    • (2008) AIDS Epidemic Update: 2007
  • 7
    • 0034610026 scopus 로고    scopus 로고
    • A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators
    • Lallemant M., Jourdain G., La Coeur S., et al. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. N Engl J Med. 2000 ; 343: 982-991.
    • (2000) N Engl J Med , vol.343 , pp. 982-991
    • Lallemant, M.1    Jourdain, G.2    La Coeur, S.3
  • 8
    • 3142656082 scopus 로고    scopus 로고
    • Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand
    • Lallemant M., Jourdain G., La Coeur S., et al. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med. 2004 ; 353: 217-228.
    • (2004) N Engl J Med , vol.353 , pp. 217-228
    • Lallemant, M.1    Jourdain, G.2    La Coeur, S.3
  • 9
    • 0037029419 scopus 로고    scopus 로고
    • Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): A randomised, double-blind, placebo-controlled trial
    • Saba J., Haverkamp G., Gray G., McIntyre J., Mmiro F. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial. Lancet. 2002 ; 359: 1178-1186.
    • (2002) Lancet , vol.359 , pp. 1178-1186
    • Saba, J.1    Haverkamp, G.2    Gray, G.3    McIntyre, J.4    Mmiro, F.5
  • 11
    • 27544460616 scopus 로고    scopus 로고
    • Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa?
    • Leroy V., Sakarovitch C., Cortina-Borja M., et al. Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa? AIDS. 2005 ; 19: 1865-1875. (Pubitemid 41546606)
    • (2005) AIDS , vol.19 , Issue.16 , pp. 1865-1875
    • Leroy, V.1    Sakarovitch, C.2    Cortina-Borja, M.3    McIntyre, J.4    Coovadia, H.5    Dabis, F.6    Newell, M.-L.7
  • 14
    • 0037415049 scopus 로고    scopus 로고
    • Compliance with antiretroviral regimens to prevent perinatal HIV-1 transmission in Kenya
    • DOI 10.1097/00002030-200301030-00009
    • Kiarie JN, Kreiss JK, Richardson BA, John-Stewart GC Compliance with antiretroviral regimens to prevent perinatal HIV-1 transmission in Kenya. AIDS. 2003 ; 17: 65-71. (Pubitemid 36106299)
    • (2003) AIDS , vol.17 , Issue.1 , pp. 65-71
    • Kiarie, J.N.1    Kreiss, J.K.2    Richardson, B.A.3    John-Stewart, G.C.4
  • 20
    • 33646019575 scopus 로고    scopus 로고
    • Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmission
    • Jackson JB, Parsons T., Musoke P., et al. Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmission. AIDS. 2006 ; 20: 217-222.
    • (2006) AIDS , vol.20 , pp. 217-222
    • Jackson, J.B.1    Parsons, T.2    Musoke, P.3
  • 25
    • 0035479290 scopus 로고    scopus 로고
    • Impact of human immunodeficiency virus type 1 (HIV-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent HIV-1 vertical transmission (HIV Network for Prevention Trials 012 study)
    • Eshlemann SH, Becker-Pergola G., Deseyve M., et al. Impact of human immunodeficiency virus type 1 (HIV-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent HIV-1 vertical transmission (HIV Network for Prevention Trials 012 study). J Infect Dis. 2001 ; 184: 914-917.
    • (2001) J Infect Dis , vol.184 , pp. 914-917
    • Eshlemann, S.H.1    Becker-Pergola, G.2    Deseyve, M.3
  • 26
  • 29
    • 22344443325 scopus 로고    scopus 로고
    • Nevirapine plasma concentrations are still detectable after more than 2 weeks in the majority of women receiving single-dose nevirapine: Implications for intervention studies
    • DOI 10.1097/01.qai.0000167154.37357.f9
    • Muro E., Droste JAH, ter Hofstede H., Bosch M., Dolmans W., Burger D. Nevirapine plasma concentrations are still detectable after more than 2 weeks in the majority of women receiving single-dose nevirapine: implications for intervention studies. J Acquir Immune Defic Syndr. 2005 ; 39: 419-421. (Pubitemid 41003786)
    • (2005) Journal of Acquired Immune Deficiency Syndromes , vol.39 , Issue.4 , pp. 419-421
    • Muro, E.1    Droste, J.A.H.2    Ter Hofstede, H.3    Bosch, M.4    Dolmans, W.5    Burger, D.M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.